Patent details
EP2769737 Title: Combination of an anti-CTLA4 antibody with etoposide for the synergistic treatment of proliferative diseases
Basic Information
- Publication number:
- EP2769737
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP141626135
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Combination of an anti-CTLA4 antibody with etoposide for the synergistic treatment of proliferative diseases
- French Title of Invention:
- Combinaison d'anticorps anti-ctla4 avec etoposide pour le traitement synergique de prolifération
- German Title of Invention:
- Kombination aus einem Anti-CTLA4-Antikörper mit Etoposide für die synergistische Behandlung proliferativer Erkrankungen
- SPC Number:
Dates
- Filing date:
- 29/10/2009
- Grant date:
- 05/04/2017
- EP Publication Date:
- 27/08/2014
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 05/04/2017
- EP B1 Publication Date:
- 05/04/2017
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 29/10/2029
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 05/04/2017
- Name:
- Bristol-Myers Squibb Company
- Address:
- Route 206 and Province Line Road, Princeton, NJ 08543, United States (US)
Agent
- Name:
- MARKS & CLERK LLP
- From:
- 02/05/2017
- Address:
- BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
- To:
Inventor
1
- Name:
- Lee, Francis, Y.
- Address:
- United States (US)
2
- Name:
- Jure-Kunkel, Maria
- Address:
- United States (US)
Priority
1
- Priority Number:
- 226910 P
- Priority Date:
- 20/07/2009
- Priority Country:
- United States (US)
2
- Priority Number:
- 462168
- Priority Date:
- 30/07/2009
- Priority Country:
- United States (US)
3
- Priority Number:
- PCT/US2009/052209
- Priority Date:
- 30/07/2009
- Priority Country:
- World Intellectual Property Office (WIPO) (WO)
Classification
- IPC classification:
- A61K 31/337; A61K 31/385; A61K 31/506; A61K 33/24; A61K 39/00; A61K 39/395; A61K 45/06; C07K 16/28;
Publication
European Patent Bulletin
- Issue number:
- 201714
- Publication date:
- 05/04/2017
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- 02/11/2026
- Annual Fee Number:
- 18
- Annual Fee Amount:
- 262 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 16/10/2025
- Last Annual Fee Paid Number:
- 17
- Last Annual Fee Paid Amount:
- 246 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|---|---|
| 03/05/2017 | Outgoing Correspondence | 1 |
| 12/08/2022 | Request For Change | 1 |
| 02/09/2022 | Outgoing Correspondence | 56 |
| 02/05/2017 | Power Of Attorney | 1 |